Los Angeles, CA. Nixon Peabody LLP is pleased to have represented Hanabusa IVF and Asian Egg Bank in their partnership with CSG.BIO.
Hanabusa IVF is a premier private fertility clinic located in San Diego, California, providing advanced reproductive care, including mini-IVF, low-stimulation treatment, and comprehensive genetic testing. Asian Egg Bank is a donor egg bank focused on helping intended parents and fertility clinics access Asian donor options.
“This transaction enables the companies to expand specialized fertility platforms to meet increased demand. We are excited to see the many positive contributions they will make,” said Nixon Peabody Healthcare partner Alexandra Busto, who leads the firm’s Reproductive Medicine and Sexual Health Legal team.
Healthcare counsel Patrick Callaghan, who co-led the transaction with Busto, added, “We are proud to support Hanabusa IVF and Asian Egg Bank as they continue to grow and advance access to fertility care."
Nixon Peabody’s Reproductive Medicine and Sexual Health Legal team brings deep experience navigating the complex transactional and regulatory landscape in the reproductive medicine sector, partnering with innovators, investors, and clinicians to leverage opportunities in the rapidly growing space of reproductive medicine, fertility, and sexual health services. Handling matters ranging from regulatory compliance and litigation issues to corporate structuring, capital raising, and platform expansion, our experienced team of lawyers is committed to providing comprehensive support to all aspects of reproductive health companies.
In addition to Busto and Callaghan, the Nixon Peabody team included associates Vidaur Durazo, Meredith LaMaster, and Sravya Rallapalli. Provident Healthcare Partners served as the lead investment banker to Hanabusa IVF and Asian Egg Bank.
For more details on the transaction, see the press release.
